bioRASI to Present at the 60th Indian Pharmaceutical Congress in New Delhi, India (Marketwire via Yahoo! Finance)
bioRASI announced today that it will be participating in the 60th Indian Pharmaceutical Congress in New Delhi, India on Dec. 12th - 14th. Dr. Reznik, CEO of bioRASI, will be a keynote speaker at the event's Symposium, and will be giving a presentation focused on optimizing drug development programs for ANDA and 505(b)(2) NDA FDA submissions. In addition, bioRASI will be exhibiting in Hall D, at ...

Lawmakers Debate Picks For FDA Chief; Possibilities Include Drug Safety Director Woodcock (Medical News Today)
Debate over whether any current FDA officials should be named as successor to current FDA Commissioner Andrew von Eschenbach and how quickly the decision should be announced is dividing congressional officials, "reflecting a divergence of views ... on how to fix the FDA's problems," the Wall Street Journal reports.

Presents or Coal From the FDA? (The Motley Fool)
Will the FDA approve these drugs?